Biotech wants tax break

Biotech industry executives are beseeching Congress today (10 Dec) for a temporary change in the tax code that would give some struggling biotech companies a cash boost. The plan would funnel hundreds of millions of dollars to some biotechs in exchange for tax credits that the companies would not take if they make money next year and beyond. Nearly a third of publically traded American biotech companies have a six month's or less supply of operating cash, The New York Times linkurl:reported.;h